Check out the companies making the biggest moves premarket: McCormick — Shares rose more than 3% after Unilever confirmed it was in talks with the spices maker over a potential transaction to merge Unilever Foods with McCormick. If a deal were to take place, the Unilever news release said, it would involve “an upfront cash component of approximately US$15.7 billion and the majority of the consideration in McCormick equity. Upon completion of the transaction, it is expected that Unilever and its shareholders would hold 65% of the combined company.” Diageo — The spirits giant climbed nearly 3% after an upgrade to buy from hold at Deutsche Bank. The bank said “structural and cyclical headwinds” such as weakness in alcohol sales are already priced into the stock. Amphenol — The maker of system sensors and antennas gained more than 2% following an upgrade to buy from hold at Jefferies. Analysts at the bank pointed to strong order growth and solid margins for the rating change. Big Tech — The group rose alongside the broader market after a report said President Donald Trump is looking to end the Iran war without reopening the Strait of Hormuz. Meta Platforms and Microsoft climbed more than 1% each. Nvidia and Apple advanced 0.9% and 0.6%, respectively. The four names are lower since the conflict began. Nike — Shares of the athletic shoe maker rose 1.3% ahead of the company’s earnings results set to release Tuesday after the close. Apellis Pharmaceuticals – Shares doubled, up 138%, after Biogen announced it will acquire the company for $5.6 billion in cash. Biogen said the deal will enhance its portfolio in immunology and rare disease. Centessa Pharmaceuticals — The drugmaker surged nearly 48% after Eli Lilly said it agreed to buy the company. Lilly said in a press release the acquisition would help advance work Centessa is doing on treating excessive daytime sleepiness and other neurological conditions. Novo Nordisk — Shares slipped 0.3% after the company announced a multimonth subscription plan for its obesity drug Wegovy products. The plan is expected those paying with cash for the drugs money, up to $1,200 on the injection and $600 on the pill per year, as the company looks to compete more with Eli Lilly which dominates the U.S. GLP-1 market. Marvell Technology – Shares jumped 11% after an announcement that Nvidia will be investing $2 billion in the company as part of a strategic partnership. Nvidia said it plans to connect Marvell to its AI factor and radio access network ecosystems. — CNBC’s Sarah Min and Davis Giangiulio contributed reporting.
Add A Comment
About Us
Our finance blog is your go-to resource for expert financial advice, covering everything from personal budgeting and saving strategies to smart investing and market analysis. Stay updated with the latest trends, tips, and insights to help you make informed decisions and achieve financial success.
Popular Post
© 2026 Finderica.com – All rights reserved.